Significant change:Amendments to relevant sections of the SPC following the endorsement by the
European Commission of the CVMP Opinion on the Article 83 referral regarding
VMPs containing N-methyl pyrrolidone as an excipient. The outcome agreed at
EU level should also be applied to all impacted GB and UK-wide licences.